Are you Dr. Rainwater?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1355 River Bend Dr
Dallas, TX 75247Phone+1 214-237-1715Fax+1 214-237-1743
Summary
- Dr. Yevgeniya (Byekova) Rainwater, MD is a board certified dermatologist in Dallas, Texas. She is currently licensed to practice medicine in Texas, Massachusetts, and Rhode Island. She is affiliated with University of Texas Southwestern Medical Center and Parkland Health.
Education & Training
- University of Texas Southwestern Medical CenterResidency, Dermatology, 2013 - 2016
- HCA HealthONE /Presbyterian-St Luke’s Medical CenterInternship, Transitional Year, 2012 - 2013
- University of Alabama School of MedicineClass of 2012
Certifications & Licensure
- IA State Medical License 2020 - 2026
- IL State Medical License 2019 - 2026
- MA State Medical License 2021 - 2026
- RI State Medical License 2021 - 2026
- TX State Medical License 2016 - 2026
- CA State Medical License 2019 - 2025
- CT State Medical License 2020 - 2025
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsTranscriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea.Jack C. O’Brien, Yevgeniya B. Rainwater, Neeta Malviya, Nika Cyrus, Lorenz Auer-Hackenberg
The Journal of Investigative Dermatology. 2017-08-01 - 1 citationsAutoantigen microarrays reveal myelin basic protein autoantibodies in morphea.Jane L Zhu, Ricardo T Paniagua, Henry W Chen, Stephanie Florez-Pollack, Elaine Kunzler
Journal of Translational Medicine. 2022-01-24 - 10 citationsRegarding "Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea".Jorre S. Mertens, E.M.G.J. de Jong, Aridaman Pandit, Marieke M B Seyger, Esther P A H Hoppenreijs
The Journal of Investigative Dermatology. 2018-05-01